Srinivas Akkaraju bought $11.9M of Scholar Rock Holding (SRRK)
Executed Oct 23, disclosed Oct 27, 4 days later.
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
Srinivas Akkaraju (Director) filed 12 Form 4 reports in the trailing twelve months (12 purchases, 1 sale, 2 filed past the two-business-day deadline; 1 filing reported both), most often in Alumis Inc. (ALMS). Across 11 priced purchase filings, the average 21-session return was +35.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $11.9M of SRRK (287,970 sh across 4 lots, as filed), executed Oct 23.
Healthcare · Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→29,599 sh across 3 lots
Exec Oct 7 2025
Filed Dec 16 2025 · 9:07 PM ET † SRRKPURCHASE Scholar Rock Holding Corporation $18.8M
500,439 sh across 6 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 8:59 PM ET